13F filing recap · Q2 2023
What did Fairfax Financial Holdings buy in Q2 2023?
Reported stock-position changes between this filing and the previous one.
Stock value
$1.53B
Positions
60
Estimated turnover
28.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
DICEDice Therapeutics Inc$6.04Mreported value+130.0K sharesATSAts Corp /ats$1.84Mreported value+40.0K sharesEPAMEpam Systems, Inc.$1.56Mreported value+7.0K sharesCPCanadian Pacific Kansas City Ltd/cn$1.21Mreported value+15.0K sharesARCEArco Platform Ltd$763.6Kreported value+63.2K sharesCNSLConsolidated Communications Holdings, Inc.$302.0Kreported value+78.8K shares